Telescoping pipeline vantage embolization devices with shield technology for the treatment of a giant, symptomatic dolichoectatic basilar trunk aneurysm

BACKGROUND: Dolichoectatic basilar trunk aneurysms are exceedingly rare and carry a poor prognosis. Treatment strategies are often reserved for patients with severe and progressive symptoms. CASE DESCRIPTION: A patient in their 40s with a dolichoectatic basilar trunk aneurysm developed significant p...

Descripción completa

Detalles Bibliográficos
Autores principales: Hackett, Ashia M., Luther, Evan M., Walker, Ariel P., Burks, Joshua, Lu, Victor M., Silva, Michael A., Starke, Robert M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientific Scholar 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610930/
https://www.ncbi.nlm.nih.gov/pubmed/36324986
http://dx.doi.org/10.25259/SNI_701_2022
Descripción
Sumario:BACKGROUND: Dolichoectatic basilar trunk aneurysms are exceedingly rare and carry a poor prognosis. Treatment strategies are often reserved for patients with severe and progressive symptoms. CASE DESCRIPTION: A patient in their 40s with a dolichoectatic basilar trunk aneurysm developed significant progression of the lesion and neurologic decline, necessitating treatment. He underwent flow diversion utilizing multiple telescoping Pipeline Vantage Embolization Devices with Shield Technology for treatment. At 1-year follow-up, the aneurysm was stable in size and the patient remained at his neurologic baseline. CONCLUSION: This case illustrates the need for continued development of next-generation endovascular devices as these aneurysms have limited management options.

Ejemplares similares